Discordance of endothelial nitric oxide synthase in the arterial wall and its circulating products in baboons: Interactions with redox metabolism

European Journal of Clinical Investigation

Volumn 33, Issue 4, 2003, Pages 288-295

  Wang, J ^a   Felux, D ^a   VandeBerg, J ^a   Wang, X L ^a  

^a SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

Arteries; Coronary disease; Endothelium derived factors; Free radicals; Plasma

Indexed keywords

ADVANCED GLYCATION END PRODUCT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL TISSUE; AORTA; ARTERY WALL; ARTICLE; AUTOPSY; BABOON; BRACHIAL ARTERY; CAROTID ARTERY; CONTROLLED STUDY; CORONARY ARTERY; CORRELATION COEFFICIENT; ENZYME IMMUNOASSAY; FEMALE; MALE; MEASUREMENT; METABOLISM; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTIOXIDANTS; ARTERIES; BRACHIAL ARTERY; CAROTID ARTERIES; CORONARY VESSELS; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLYCOSYLATION END PRODUCTS, ADVANCED; NITRATES; NITRIC OXIDE SYNTHASE; NITRITES; OXIDATION-REDUCTION; PAPIO;

EID: 0037392280     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2003.01143.x     Document Type: Article

References (34)

1. Stary HC. Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults. Arteriosclerosis 1989;9:I19-32.
2. Schwartz CJ, Valente AJ, Sprague EA. A modern view of atherogenesis. Am J Cardiol 1993;71:9B-14B.
3. Glagov S, Zarins C, Giddens DP, Ku DN. Hemodynamics and atherosclerosis. Insights and perspectives gained from studies of human arteries. Arch Pathol Lab Med 1988;112:1018-31.
4. van der Heijden-Spek JJ, Staessen JA, Fagard RH, Hoeks AP, Boudier HA, van Bortel LM. Effect of age on brachial artery wall properties differs from the aorta and is gender dependent: a population study. Hypertension 2000;35:637-42.
5. Jost S, Deckers JW, Nikutta P, Rafflenbeul W, Wiese B, Hecker H et al. Progression of coronary artery disease is dependent on anatomic location and diameter. The INTACT investigators. J Am Coll Cardiol 1993;21:1339-46.
6. Kimura BJ, Russo RJ, Bhargava V, McDaniel MB, Peterson KL, DeMaria AN. Atheroma morphology and distribution in proximal left anterior descending coronary artery: in vivo observations. J Am Coll Cardiol 1996;27:825-31.
7. Ravensbergen J, Ravensbergen JW, Krijger JK, Hillen B, Hoogstraten HW. Localizing role of hemodynamics in atherosclerosis in several human vertebrobasilar junction geometries. Arterioscler Thromb Vasc Biol 1998;18:708-16.
8. Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol 1994;24:1468-74.
9. Celermajer DS. Testing endothelial function using ultrasound. J Cardiovasc Pharmacol 1998;32:S29-32.
10. Rothwell PM. Carotid artery disease and the risk of ischaemic stroke and coronary vascular events. Cerebrovasc Dis 2000;10:21-33.
11. Aminbakhsh A, Mancini GB. Carotid intima-media thickness measurements: what defines an abnormality? A systematic review. Clin Invest Med 1999;22:149-57.
12. Probstfield JL, Byington RP, Egan DA, Espeland MA, Margitic SE, Riley WA Jr, Furberg CD. Methodological issues facing studies of atherosclerotic change. Circulation 1993;87:II74-81.
13. Mercuri M. Noninvasive imaging protocols to detect and monitor carotid atherosclerosis progression. Am J Hypertens 1994;7:23S-29S.
14. Stary HC, Blankenhorn DH, Chandler AB, Glagov S, Insull W Jr, Richardson M et al. A definition of the intima of human arteries and of its atherosclerosis-prone regions. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb 1992;12:120-34.
15. Badimon JJ, Ortiz AF, Meyer B, Mailhac A, Fallon JT, Falk E et al. Different response to balloon angioplasty of carotid and coronary arteries effects on acute platelet deposition and intimal thickening. Atherosclerosis 1998;140:307-14.
16. Harrison DG. Endothelial function and oxidant stress. Clin Cardiol 1997;20:II-11-7.
17. Rudic RD, Sessa WC. Nitric oxide in endothelial dysfunction and vascular remodeling, clinical correlates and experimental links. Am J Hum Genet 1999;64:673-7.
18. Rudic RD, Shesely EG, Maeda N, Smithies O, Segal SS, Sessa WC. Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling. J Clin Invest 1998;101:731-6.
19. Wink DA, Vodovotz Y, Grisham MB, DeGraff W, Cook JC, Pacelli R et al. Antioxidant effects of nitric oxide. Meth Enzymol 1999;301:413-24.
20. Tomasian D, Keaney JF, Vita JA. Antioxidants and the bioactivity of endothelium-derived nitric oxide. Cardiovasc Res 2000;47:426-35.
21. Wang XL, Rainwater DL, VandeBerg JF, Mitchell BD, Mahaney MC. Genetic contributions to plasma total antioxidant activity. Arterioscler Thromb Vasc Biol 2001;21:1190-5.
22. Baynes JW, Thorpe SR. Glycoxidation and lipoxidation in atherogenesis. Free Radic Biol Med 2000;28:1708-16.
23. Schmidt AM, Yan SD, Wautier JL, Stern D. Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ Res 1999;84:489-97.
24. Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 1999;48:1-9.
25. Monnier VM. Transition metals redox: reviving an old plot for diabetic vascular disease. J Clin Invest 2001;107:799-801.
26. Wang XL, Mahaney MC, Sim AS, Wang J, Blangero J, Almasy L et al. Genetic contribution of the endothelial constitutive nitric oxide synthase gene to plasma nitric oxide levels. Arterioscler Thromb Vasc Biol 1997;17:3147-53.
27. Mitsuhashi T, Vlassara H, Founds HW, Li YM. Standardizing the immunological measurement of advanced glycation endproducts using normal human serum. J Immunol Meth 1997;207:79-88.
28. Marletta MA. Nitric oxide synthase: aspects concerning structure and catalysis. Cell 1994;78:927-30.
29. Wang Y, Newton DC, Marsden PA. Neuronal NOS. gene structure, mRNA diversity, and functional relevance. Crit Rev Neurobiol 1999;13:21-43.
30. Wilcox JN, Subramanian RR, Sundell CL, Tracey WR, Pollock JS, Harrison DG et al. Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels. Arterioscler Thromb Vasc Biol 1997;17:2479-88.
31. Venema RC, Ju H, Zou R, Ryan JW, Venema VJ. Subunit interactions of endothelial nitric-oxide synthase. Comparisons to the neuronal and inducible nitric-oxide synthase isoforms. J Biol Chem 1997;272:1276-82.
32. Wang J, Brown MA, Tam SH, Chan MC, Whitworth JA. Effects of diet on measurement of nitric oxide metabolites. Clin Exp Pharmacol Physiol 1997;24:418-20.
33. Prior RL, Cao G. In vivo total antioxidant capacity: comparison of different analytical methods. Free Radic Biol Med 1999;27:1173-81.
34. Duthie GG. Determination of activity of antioxidants in human subjects. Proc Nutr Soc 1999;58:1015-24.